Beta-interferon, retinoids and tamoxifen in metastatic breast cancer: Long-term follow-up of a phase II study

Oncology Reports ◽

10.3892/or_00000317 ◽

2009 ◽

Vol 21 (4) ◽

Author(s):

Recchia

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Beta Interferon ◽

Long Term Follow Up

Download Full-text

Maintenance immunotherapy in patients with metastatic breast cancer (MBC) who have a clinical benefit with chemotherapy. Long-term follow-up of a phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e13068 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e13068-e13068 ◽

Author(s):

Francesco Recchia

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Clinical Benefit ◽

Phase Ii Study ◽

Metastatic Breast ◽

Long Term Follow Up

Download Full-text

Abstract P6-16-06: Maintenance immunotherapy in estrogen receptor negative (ER-) locally advanced (LA) and/or metastatic breast cancer (MBC). Long-term follow-up of a phase II study

10.1158/1538-7445.sabcs16-p6-16-06 ◽

2017 ◽

Author(s):

F Recchia ◽

G Candeloro ◽

S Rea

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Metastatic Breast Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Metastatic Breast ◽

Long Term Follow Up ◽

Estrogen Receptor Negative

Download Full-text

Phase II study of the combination of oral vinorelbine (NVBo), capecitabine (X), and trastuzumab (H) in HER2-positive, metastatic breast cancer (MBC): Recent analysis of the results with a median follow-up of 44 months.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.1077 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 1077-1077 ◽

Author(s):

L. B. Petruzelka ◽

V. Ganju ◽

D. Becquart ◽

P. F. Conte ◽

N. Tubiana-Mathieu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Recent Analysis ◽

Her2 Positive ◽

Oral Vinorelbine

Download Full-text

Total estrogen blockade and chemotherapy in high-risk premenopausal early breast cancer (BC): Long-term follow-up of a phase II study.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.537 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 537-537

Author(s):

Francesco Recchia ◽

Giampiero Candeloro ◽

Alisia Cesta ◽

Stefano Necozione ◽

Silvio Rea ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Early Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Long Term Follow Up

Download Full-text

Abstract P1-13-07: Superiority of tandem high-dose chemotherapy (HDC) versus conventionally dosed chemotherapy (CDC) in patients with metastatic breast cancer (MBC): Long term follow-up of IBDIS: A prospective random assignment trial (PRT)

10.1158/1538-7445.sabcs15-p1-13-07 ◽

2016 ◽

Author(s):

J Crown

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

High Dose Chemotherapy ◽

High Dose ◽

Random Assignment ◽

Long Term Follow Up

Download Full-text

Long-term follow-up of patients with metastatic breast cancer

Anti-Cancer Drugs ◽

10.1097/cad.0b013e32834860af ◽

2011 ◽

Vol 22 (9) ◽

pp. 933-939 ◽

Author(s):

Sandra Geiger ◽

Jitske Alida Cnossen ◽

Sophia Horster ◽

Dorit DiGioia ◽

Volker Heinemann ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Metastatic Breast ◽

Long Term Follow Up

Download Full-text

Multicenter international phase II study of oral vinorelbine (NVBo), capecitabine (X) and trastuzumab (H) triple combination in HER2-positive metastatic breast cancer (MBC): updated results with a longer follow-up.

10.1158/0008-5472.sabcs-3151 ◽

2009 ◽

Author(s):

A Chan ◽

V Ganju ◽

D Becquart ◽

P Conte ◽

L Petruzelka ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

Triple Combination ◽

Her2 Positive ◽

Oral Vinorelbine

Download Full-text

Abstract P6-09-06: Estrogen (E2) suppression following diagnosis of node positive (N+) breast cancer (BC) in premenopause. Long term follow-up of a phase II study

10.1158/0008-5472.sabcs13-p6-09-06 ◽

2013 ◽

Author(s):

F Recchia ◽

G Candeloro ◽

A Cesta ◽

ML Evangelista ◽

G Desideri ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Node Positive ◽

Long Term Follow Up

Download Full-text

Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up: the M.D. Anderson experience

Cancer Chemotherapy and Pharmacology ◽

10.1007/s002800050926 ◽

1999 ◽

Vol 43 (6) ◽

pp. 471-478 ◽

Author(s):

Nuhad K. Ibrahim ◽

Gabriel N. Hortobagyi ◽

Michael Ewer ◽

Mohammed K. Ali ◽

Lina Asmar ◽

...

Keyword(s):

Breast Cancer ◽

Heart Failure ◽

Congestive Heart Failure ◽

Metastatic Breast Cancer ◽

Elderly Patients ◽

Metastatic Breast ◽

Long Term Follow Up

Download Full-text

Long-term follow up (FU) of patients with durable complete response (DCR) after chemotherapy (CT) and HER2-targeting systemic therapy (HER2-Tx) for HER2+ metastatic breast cancer (MBC).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.641 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 641-641

Author(s):

Giuseppe Gullo ◽

Annamaria De Giorgi ◽

Cecily Quinn ◽

Jo Ballot ◽

Lisa Hammond ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Systemic Therapy ◽

Metastatic Breast ◽

Complete Response ◽

Long Term Follow Up ◽

Durable Complete Response

Download Full-text